E-LIB Suche - Ergebnisse für: Brady, Mark F

1

Treatment of Scorpion Envenomations in the Middle East: Und..:

Brady, Mark F. ; Kumar, Prasanna ; Currier, Chase.
Wilderness & Environmental Medicine. 34 (2023) 2 - p. 258-260 , 2023

Link: https://doi.org/10.1016/..

2

Prognostic significance of ethnicity and age in advanced st..:

duPont, Nefertiti C. ; Enserro, Danielle ; Brady, Mark F....
Gynecologic Oncology. 164 (2022) 2 - p. 398-405 , 2022

Link: https://doi.org/10.1016/..

3

Correlation of imaging and plasma based biomarkers to predi..:

Buechel, Megan E. ; Enserro, Danielle ; Burger, Robert A....
Gynecologic Oncology. 161 (2021) 2 - p. 382-388 , 2021

Link: https://doi.org/10.1016/..

4

Pulse oximeter plethysmograph waveform and automated oscill..:

Arnold, Cosby G. ; Walker, J. Richard ; Metter, E. Jeffrey..
The American Journal of Emergency Medicine. 40 (2021) - p. 162-165 , 2021

Link: https://doi.org/10.1016/..

5

Association of race and socioeconomic status with the rate ..:

Justice, Joshua M. ; Holley, Joseph E. ; Brady, Mark F..
Journal of the American College of Emergency Physicians Open. 1 (2020) 4 - p. 440-444 , 2020

Link: https://doi.org/10.1002/..

6

Alternatives to opioid protocols in Colorado emergency depa..:

Stader, Donald ; Wald, Heidi ; Rossi MacKay, Diane...
Journal of the American College of Emergency Physicians Open. 1 (2020) 6 - p. 1493-1499 , 2020

Link: https://doi.org/10.1002/..

7

Gynecological Cancers Translational, Research Implementatio..:

Bagnoli, Marina ; Shi, Ting Yan ; Gourley, Charlie...
Cells. 8 (2019) 3 - p. 200 , 2019

Link: https://doi.org/10.3390/..

8

Bevacizumab and paclitaxel–carboplatin chemotherapy and sec..:

Coleman, Robert L ; Brady, Mark F ; Herzog, Thomas J...
The Lancet Oncology. 18 (2017) 6 - p. 779-791 , 2017

Link: https://doi.org/10.1016/..

9

Tumor Microvessel Density as a Potential Predictive Marker ..:

Bais, Carlos ; Mueller, Barbara ; Brady, Mark F...
JNCI: Journal of the National Cancer Institute. 109 (2017) 11 - p. , 2017

Link: https://doi.org/10.1093/..

10

Ovarian cancer clinical trial endpoints: Society of Gynecol..:

Herzog, Thomas J. ; Armstrong, Deborah K. ; Brady, Mark F....
Gynecologic Oncology. 132 (2014) 1 - p. 8-17 , 2014

Link: https://doi.org/10.1016/..

11

Independent radiologic review of the Gynecologic Oncology G..:

Burger, Robert. A. ; Brady, Mark F. ; Rhee, Joon...
Gynecologic Oncology. 131 (2013) 1 - p. 21-26 , 2013

Link: https://doi.org/10.1016/..

12

CA125 regression in ovarian cancer patients treated with in..:

Gardner, Ginger J. ; Baser, Raymond E. ; Brady, Mark F....
Gynecologic Oncology. 124 (2012) 2 - p. 216-220 , 2012

Link: https://doi.org/10.1016/..

13

Cytokine use and survival in the first-line treatment of ov..:

Stehman, Frederick B. ; Brady, Mark F. ; Thigpen, J. Tate..
Gynecologic Oncology. 127 (2012) 3 - p. 495-501 , 2012

Link: https://doi.org/10.1016/..

14

A randomized phase III trial of IV carboplatin and paclitax..:

Mannel, Robert S. ; Brady, Mark F. ; Kohn, Elise C....
Gynecologic Oncology. 122 (2011) 1 - p. 89-94 , 2011

Link: https://doi.org/10.1016/..

15

Improved survival in non-Ashkenazi Jewish ovarian cancer pa..:

Lacour, Robin A. ; Westin, Shannon N. ; Meyer, Larissa A....
Gynecologic Oncology. 121 (2011) 2 - p. 358-363 , 2011

Link: https://doi.org/10.1016/..